@inproceedings{inproceedings, title  = {{Integrated Analysis of Abrocitinib for the Treatment of Adolescents with Moderate-to-Severe Atopic Dermatitis From the Phase 3 Clinical Trial Program}},

 url = {{}},

 year = {{2023}},

 month = {{1}},

 author = {{Paller A and Eichenfield LF and Cork MJ and Bangert C and Irvine AD and Weidinger S and Johnson S and Lazariciu I and Koppensteiner H}},

 volume = {{21}},

 journal = {{JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT}},

 pages = {{77-77}},

 note = {{Accessed on 2024/12/22}}}